Temc CNS

At a glance

Temc CNS filed 24 disclosures in the last 12 months, including 3 insider, 2 contract and 1 buyback. The most recent key filing was on Aug 31: Signed a ₩3B trust contract to buy back shares.

Revenue for 2025 was ₩168B, down 13.2% on 2024. Operating margin was 5.4% against 3.1% a year earlier. Debt was 45% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩79.2B and operating loss of ₩3.5B.

The 2025 annual report lists 160 employees with an average tenure of 3.9 years and average pay of ₩57.4M, #1304 of 2,191 listed companies by average pay. Its 5 directors and auditors were paid ₩223M each on average. It paid ₩70 per common share in cash dividends, against ₩150 a year earlier (-53.3%). 티이엠씨 주식회사 and related parties held 33.55% at year end.

From the 2025 annual report

Staff: 160 (140 men, 20 women), of whom 1 on fixed-term contracts. Total pay for the year: ₩9.2B. Directors and auditors: 5, paid ₩1.1B in total.

Dividends (common shares)

Largest shareholder

티이엠씨 주식회사 holds 33.40%; with 1 related party the group holds 33.55% of common shares at year end.

Auditor: 삼정회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

New contracts, last 12 months

2 new supply contracts worth 24% of the revenue stated in the filings.

Amended amounts replace the originals. Subsidiary contracts and terminations are excluded.

Financial summary